Pharmaxi Poland Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

Secondary Activities: Data Processing, Hosting, and Related Services | Other Information Services | Computer Systems Design and Related Services | Performing Arts Companies | Commercial and Industrial Machinery and Equipment (except Automotive and Electronic) Repair and Maintenance

Full name: Pharmaxi Poland Sp. z o.o.

Profile Updated: March 29, 2025

Pharmaxi Poland Sp. z o.o. is a company in Poland, with a head office in Warsaw. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on March 24, 2022. The company’s latest financial report indicates a net sales revenue increase of 7.23% in 2024. Its total assets decreased by 1.44% over the same period.

Headquarters
Ul. Korytnicka 46/52
Warsaw; Mazowieckie; Postal Code: 04-109

Contact Details: Purchase the Pharmaxi Poland Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Pharmaxi Poland Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Pharmaxi Poland Sp. z o.o. report to view the information.

Incorporation Date:

March 24, 2022

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

Proxy

Ownership Details

Purchase this report to view the information.

81%

Purchase this report to view the information.

19%

Company Performance

Financial values in the chart are available after Pharmaxi Poland Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

7.23%▲

Total operating revenue

6.85%▲

Operating Profit/Loss (EBIT)

N/A

EBITDA

N/A

Net Profit/Loss for the Period

N/A

Total Assets

-1.44%▼

Total Equity

-0.67%▼

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Similar companies